Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.

Vesna Jurcić, Dusan Ferluga
{"title":"Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.","authors":"Vesna Jurcić,&nbsp;Dusan Ferluga","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>It has been shown that adhesion molecules are upregulated on different structures in kidney during allograft rejection. Although vascular endothelium is one of the major targets in rejection, little is known about the expression of adhesion molecules in kidney vasculature.</p><p><strong>Methods: </strong>Expression of adhesion molecules ICAM-1, VCAM-1 and E-selectin, and activation markers HLA-DR and IL2R was investigated in different vascular segments of nephrectomy specimens in 8 kidney allografts with acute and 5 with chronic rejection.</p><p><strong>Results: </strong>In acute rejection, ICAM-1, VCAM-1 and HLA-DR were strongly upregulated on the endothelium and IL2R on inflammatory cells of all vessels. In chronic rejection, ICAM-1, VCAM-1 and HLA-DR were less intensive and focal, with the exception of peritubular capillaries and small veins in which VCAM-1 and HLA-DR were significantly upregulated.</p><p><strong>Conclusion: </strong>Upregulation of adhesion molecules in acute rejection is probably important in inflammatory infiltration of tubulointerstitium and vessels, as a part of cellular immune mechanisms. Cellular immunity is also supported by finding of IL2R positive activated lymphocytes. In chronic rejection, upregulation of VCAM-1 and HLA-DR on capillaries and small veins may be one of the important etiological factors, explaining the characteristic interstitial and perivascular inflammation. Inflammatory cell infiltration of fibrosed vessel walls in chronic rejection was, as well as the expression of adhesion molecules, low-grade and focal. These findings are in accordance with the general opinion that the pathogenesis of chronic rejection is more complex than in acute rejection, and that, in addition to cellular response, probably include other mechanisms.</p>","PeriodicalId":79767,"journal":{"name":"Advances in clinical pathology : the official journal of Adriatic Society of Pathology","volume":"7 1","pages":"33-7"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in clinical pathology : the official journal of Adriatic Society of Pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: It has been shown that adhesion molecules are upregulated on different structures in kidney during allograft rejection. Although vascular endothelium is one of the major targets in rejection, little is known about the expression of adhesion molecules in kidney vasculature.

Methods: Expression of adhesion molecules ICAM-1, VCAM-1 and E-selectin, and activation markers HLA-DR and IL2R was investigated in different vascular segments of nephrectomy specimens in 8 kidney allografts with acute and 5 with chronic rejection.

Results: In acute rejection, ICAM-1, VCAM-1 and HLA-DR were strongly upregulated on the endothelium and IL2R on inflammatory cells of all vessels. In chronic rejection, ICAM-1, VCAM-1 and HLA-DR were less intensive and focal, with the exception of peritubular capillaries and small veins in which VCAM-1 and HLA-DR were significantly upregulated.

Conclusion: Upregulation of adhesion molecules in acute rejection is probably important in inflammatory infiltration of tubulointerstitium and vessels, as a part of cellular immune mechanisms. Cellular immunity is also supported by finding of IL2R positive activated lymphocytes. In chronic rejection, upregulation of VCAM-1 and HLA-DR on capillaries and small veins may be one of the important etiological factors, explaining the characteristic interstitial and perivascular inflammation. Inflammatory cell infiltration of fibrosed vessel walls in chronic rejection was, as well as the expression of adhesion molecules, low-grade and focal. These findings are in accordance with the general opinion that the pathogenesis of chronic rejection is more complex than in acute rejection, and that, in addition to cellular response, probably include other mechanisms.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾移植急性和慢性排斥反应中粘附分子的血管表达。
目的:研究表明,在同种异体移植排斥反应中,粘附分子在肾脏不同结构上的表达上调。尽管血管内皮是排斥反应的主要靶点之一,但对肾脏血管中粘附分子的表达知之甚少。方法:观察8例急性和5例慢性排斥反应的同种异体肾切除术标本不同血管段中粘附分子ICAM-1、VCAM-1、e -选择素及活化标志物HLA-DR、IL2R的表达。结果:急性排斥反应中,内皮细胞上的ICAM-1、VCAM-1和HLA-DR均显著上调,炎症细胞上的IL2R显著上调。在慢性排斥反应中,除了小管周围毛细血管和小静脉中,ICAM-1、VCAM-1和HLA-DR的表达明显上调外,ICAM-1、VCAM-1和HLA-DR的表达强度和局灶性较低。结论:急性排斥反应中粘附分子的上调可能在炎症性小管间质和血管浸润中起重要作用,是细胞免疫机制的一部分。发现IL2R阳性活化淋巴细胞也支持细胞免疫。在慢性排斥反应中,毛细血管和小静脉的VCAM-1和HLA-DR的上调可能是重要的病因之一,解释了特征性的间质和血管周围炎症。慢性排斥反应中炎性细胞浸润纤维化血管壁,粘附分子表达低分级、局灶性。这些发现与一般观点一致,即慢性排斥反应的发病机制比急性排斥反应更为复杂,并且除了细胞反应外,可能还包括其他机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Confocal Laser Scanning Microscopy The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen. The mast cell: a multifunctional effector cell. Tubular differentiation in African breast cancer. Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1